Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024 With its shares suspended from the ASX amid auditor concern over its ability to keep trading, […]
Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024July 16, 2024
Australian cannabis cultivators call for industry support by Martin Lane February 22, 2024July 16, 2024
Cann Group vows to ‘vigorously’ defend Rua claims as contract dispute goes legal by Steve Jones February 16, 2024November 25, 2024
Cann Group delivers ‘modest’ growth as imports continue to frustrate by Steve Jones February 1, 2024February 1, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Cann Group inks deal to raise A$2m with more funds on the horizon by Steve Jones November 21, 2023April 30, 2024
